These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28979478)

  • 1. Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis.
    Nagendran M; Maruthappu M; Gordon AC; Gurusamy KS
    J Intensive Care Soc; 2016 May; 17(2):136-145. PubMed ID: 28979478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressors in septic shock: a systematic review and network meta-analysis.
    Zhou F; Mao Z; Zeng X; Kang H; Liu H; Pan L; Hou PC
    Ther Clin Risk Manag; 2015; 11():1047-59. PubMed ID: 26203253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials.
    Cheng L; Yan J; Han S; Chen Q; Chen M; Jiang H; Lu J
    Crit Care; 2019 May; 23(1):168. PubMed ID: 31088524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials.
    Chen C; Pang L; Wang Y; Wen T; Yu W; Yue X; Rong Y; Liao W
    Ann Transl Med; 2019 Oct; 7(20):535. PubMed ID: 31807517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressors for hypotensive shock.
    Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressors for hypotensive shock.
    Havel C; Arrich J; Losert H; Gamper G; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2011 May; (5):CD003709. PubMed ID: 21563137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
    J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis.
    Bauer SR; Wieruszewski PM; Bissell BD; Dugar S; Sacha GL; Sato R; Siuba MT; Schleicher M; Vachharajani V; Falck-Ytter Y; Morgan RL
    medRxiv; 2023 Jul; ():. PubMed ID: 37546921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
    Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
    J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
    Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
    West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.